Comparative genomic hybridization analysis of chromosomal alterations induced by the development of resistance to thymidylate synthase inhibitors

Cancer Research

Volumn 58, Issue 22, 1998, Pages 5042-5045

  Rooney, Patrick H ^a   Stevenson, David A J ^a   Marsh, Sharon ^a   Johnston, Patrick G ^b   Haites, Neva E ^a   Cassidy, James ^a   McLeod, Howard L ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; RALTITREXED; THYMIDYLATE SYNTHASE INHIBITOR;

ARTICLE; CANCER THERAPY; CELL LINE; CHROMOSOME 18P; CHROMOSOME ABERRATION; DISEASE ASSOCIATION; PRIORITY JOURNAL; THERAPY RESISTANCE;

ANTIMETABOLITES, ANTINEOPLASTIC; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, PAIR 20; DRUG RESISTANCE, NEOPLASM; FLUOROURACIL; HUMANS; NUCLEIC ACID HYBRIDIZATION; QUINAZOLINES; THIOPHENES; THYMIDYLATE SYNTHASE; TUMOR CELLS, CULTURED;

EID: 0032533513     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Curt, G. A., Clendeninn, N.J., and Chabner, B. A. Drug resistance in cancer. Cancer Treat. Rep., 68: 87-99, 1984.
2. Mulder, N. H., Timmerbosscha, H., Meersma, G. J., and Verschueren, R. J. Thymidylate synthase levels in tumor biopsies from patients with colorectal-cancer. Anticancer Res., 14: 2677-2680, 1994.
3. Kinsella, A. R., Smith, D., and Pickard, M. Resistance to chemotherapeutic antimetabolites: a function of salvage pathway involvement and cellular response to DNA damage. Br. J. Cancer, 75: 935-945, 1997.
4. Freemantle, S. J., Jackman, A. L., Kelland, L. R., Calvert, A. H., and Lunec, J. Molecular characterization of 2 cell lines selected for resistance to the folate-based thymidylate synthase inhibitor, ZD1694. Br. J. Cancer, 71: 925-930, 1995.
5. McLeod, H. L. and Keith, W. N. Variation in topoisomerase-I gene copy number as a mechanism for intrinsic drug sensitivity. Br. J. Cancer, 74: 508-512, 1996.
6. Filipits, M., Suchomel, R. W., Dekan, G., Haider, K., Valdimarsson, G., Depisch, D., and Pirker, R. Mrp and mdrl gene expression in primary breast carcinomas. Clin. Cancer Res., 2: 1231-1237, 1996.
7. Kallioniemi, A., Kallioniemi, O. P., Sudar, D., Rutovitz, D., Gray, J. W., Waldman, F., and Pinkel, D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science (Washington DC), 258: 818-821, 1992.
8. Forozan, F., Karhu, R., Kononen, J., Kallioniemi, A., and Kallioniemi, O. P. Genome screening by comparative genomic hybridization. Trends Genet., 13: 405-409, 1997.
9. Ried, T., Liyanage, M., deManoir, S., Heselmeyer, K., Auer, G., Macville, M., and Schrock, E. Tumor cytogenetics revisited: comparative genomic hybridization and spectral karyotyping. J. Mol. Med. 75: 801-814, 1997.
10. Tanner, M. M., Tirkkonen, M., Kallioniemi, A., Collins, C., Stokke, T., Karhu, R., Kowbel, D., Shadraven, F., Hintz, M., Kuo, W. L., Waldman, F. M., Isola, J. J., Gray, J. W., and Kallioniemi, O. P. Increased copy number at 20q13 in breast-cancer: defining the critical region and exclusion of candidate genes. Cancer Res., 54: 4257-4260, 1994.
11. Forus, A., Weghuis, D. O., Smeets, D., Fodstad, O., Myklebost, O., and Vankessel, A. G. Comparative genomic hybridization analysis of human sarcomas. 2. Identification of novel amplicons at 6p and 17p in osteosarcomas. Genes Chromosomes Cancer, 14: 15-21, 1995.
12. Hori, T., Takahashi, E., Ayusawa, D., Takeishi, K., Kaneda, S., and Seno, T. Regional assignment of the human thymidylate synthase (TS) gene to chromosome band 18p11.32 by nonisotopic in situ hybridization. Hum. Genet., 85: 576-580, 1990.
13. Copur, S., Aiba, K., Drake, J. C., Allegra, C. J., and Chu, E. Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil. Biochem. Pharmacol., 49: 1419-1426, 1995.
14. Drake, J. C., Allegra, C. J., Moran, R. G., and Johnston, P. G. Resistance to Tomudex (ZD1694): multifactorial in human breast and colon carcinoma cell lines. Biochem. Pharmacol., 51: 1349-1355, 1996.
15. Jackman, A. L., Farrugia, D. C., Gibson, W., Kimbell, R., Harrap, K. R., Stephens, T. C. Azab, M., and Boyle, F. T. ZD1694 (Tomudex): a new thymidylate synthase inhibitor with activity in colorectal cancer. Eur. J. Cancer, 31A: 1277-1282, 1995.
16. Diasio, R. B., and Harris, B. E. Clinical pharmacology of 5-fluorouracil. Clin. Pharmokinet., 16: 215-237, 1989.
17. Wasenius, V. M., Jekunen, A., Monni, O., Joensuu, H., Aebi, S., Howell, S. B., and Knuutila, S. Comparative genomic hybridization analysis of chromosomal changes occurring during development of acquired resistance to cisplatin in human ovarian carcinoma cells. Genes Chromosomes Cancer, 18: 286-291, 1997.
18. Guan, X. Y., Xu, J., Anzick, S. L., Zhang, H. E., Trent, J. M., and Meltzer, P. S. Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within an amplified region at 20q11-q13.2 In breast cancer. Cancer Res., 56: 3446-3450, 1996.
19. Kallioneimi, A., Kallioniemi, O. P., Piper, J., Tanner, M., Stokke, T., Chen, L., Smith, H. S. Pinkel, D., Gray, J. W., and Waldman, F. M. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc. Natl. Acad. Sci. USA 91: 2156-2160, 1994.